BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2358896)

  • 1. Side effects and long-term follow-up of corticosteroid therapy in very low birthweight infants with bronchopulmonary dysplasia.
    Ferrara TB; Couser RJ; Hoekstra RE
    J Perinatol; 1990 Jun; 10(2):137-42. PubMed ID: 2358896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dexamethasone therapy in bronchopulmonary dysplasia].
    Merz U; Kuehl G; Linderkamp O
    Klin Padiatr; 1989; 201(1):11-5. PubMed ID: 2495383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan].
    Bauer J; Beedgen B; Böhler T; Sontheimer D; Zilow EP; Linderkamp O
    Klin Padiatr; 1996; 208(2):56-60. PubMed ID: 8901183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birthweight infants.
    Jeng SF; Hsu CH; Tsao PN; Chou HC; Lee WT; Kao HA; Hung HY; Chang JH; Chiu NC; Hsieh WS
    Dev Med Child Neurol; 2008 Jan; 50(1):51-7. PubMed ID: 18173631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL;
    J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of hypogammaglobulinemia and steroid therapy in severe bronchopulmonary dysplasia.
    Wheeler W; Kurachek S; McNamara J; Fugate J; Hoogenhous N
    Pediatr Pulmonol; 1996 Aug; 22(2):96-100. PubMed ID: 8875582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe bronchopulmonary dysplasia in the very low birth weight infant: its relationship to developmental outcome.
    Goldson E
    J Dev Behav Pediatr; 1984 Aug; 5(4):165-8. PubMed ID: 6529453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ; Anbar RD; Mettelman BB
    Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year experience with neonatal ventilation from a tertiary care hospital in Delhi.
    Singh M; Deorari AK; Paul VK; Mittal M; Shanker S; Munshi U; Jain Y
    Indian Pediatr; 1993 Jun; 30(6):783-9. PubMed ID: 8132260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the new definition of bronchopulmonary dysplasia more useful?
    Sahni R; Ammari A; Suri MS; Milisavljevic V; Ohira-Kist K; Wung JT; Polin RA
    J Perinatol; 2005 Jan; 25(1):41-6. PubMed ID: 15538399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental outcome of very-low-birth-weight infants with chorioamnionitis.
    Mu SC; Lin CH; Sung TC; Chen YL; Lin YC; Lee CC; Chen TJ; Lin MI; Jow GM
    Acta Paediatr Taiwan; 2007; 48(4):207-12. PubMed ID: 18265542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two airway suctioning frequencies in mechanically ventilated, very-low-birthweight infants.
    Cordero L; Sananes M; Ayers LW
    Respir Care; 2001 Aug; 46(8):783-8. PubMed ID: 11463368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nutrition in the prevention and management of bronchopulmonary dysplasia.
    Biniwale MA; Ehrenkranz RA
    Semin Perinatol; 2006 Aug; 30(4):200-8. PubMed ID: 16860160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
    Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
    Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental patterns from 1 to 4 years of extremely preterm infants who required home oxygen therapy.
    Moon NM; Mohay HA; Gray PH
    Early Hum Dev; 2007 Apr; 83(4):209-16. PubMed ID: 16860947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants.
    Wadhawan R; Oh W; Perritt R; Laptook AR; Poole K; Wright LL; Fanaroff AA; Duara S; Stoll BJ; Goldberg R
    J Perinatol; 2007 Jun; 27(6):359-64. PubMed ID: 17443198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.